Does Prior Evidence of Macrolide Allergy Portend Subsequent Fidaxomicin Allergy?
NEJM Journal Watch: Infectious Diseases
by George Sakoulas, MD
6d ago
A global database study indicated that a macrolide allergy within the prior year, although rare itself, conferred excess risk for allergy to fidaxomicin ..read more
Visit website
Legionellosis in a Factory
NEJM Journal Watch: Infectious Diseases
by Stephen G. Baum, MD
1w ago
A respiratory outbreak of legionella in an industrial setting was caused by aerosols from factory machines ..read more
Visit website
Scrub Typhus: A Common Cause of Fever in Rural India
NEJM Journal Watch: Infectious Diseases
by Mary E. Wilson, MD
1w ago
Endemic in parts of Asia, scrub typhus accounted for almost 30% of hospitalizations for acute fever in this cohort study in southern India ..read more
Visit website
C. difficile Infection with Reduced Fidaxomicin Antibiotic Susceptibility May Develop Among Hospitalized Patients
NEJM Journal Watch: Infectious Diseases
by Neil M. Ampel, MD
1w ago
In a cohort study at a VA hospital, 5.6% of patients who received fidaxomicin had C. difficile stool isolates with reduced fidaxomicin susceptibility, some occurring after treatment ..read more
Visit website
Dengue Resurgence in Puerto Rico, 2024
NEJM Journal Watch: Infectious Diseases
by Stephen G. Baum, MD
1w ago
After an 11-year hiatus in dengue outbreaks in Puerto Rico, 2024 saw a huge increase in cases affecting mostly older children and young adults ..read more
Visit website
Observations from ID and Beyond: What Is the Future of Treatments for COVID-19?
NEJM Journal Watch: Infectious Diseases
by
2w ago
In HIV and ID Observations, Dr. Paul Sax discusses the results of the SCORPIO-HR study ..read more
Visit website
Fatal Influenza-Associated Encephalopathy Among U.S. Children
NEJM Journal Watch: Infectious Diseases
by Deborah Lehman, MD
2w ago
This devastating complication of seasonal influenza illness may be on the rise ..read more
Visit website
Changes in Body Weight and Metabolism Were Similarly Slight for LA-CAB/RPV vs. BIC/FTC/TAF
NEJM Journal Watch: Infectious Diseases
by Keith Henry, MD
2w ago
Switching to long-acting cabotegravir and rilpirivine compared with continuing oral bictegravir/emtricitabine/tenofovir alafenamide presented no clinically relevant differences in morphologic or metabolic parameters at 12 months ..read more
Visit website
Are We Giving the Right Doses of Antifungals to Critically Ill Patients?
NEJM Journal Watch: Infectious Diseases
by Thomas Glück, MD
2w ago
A prospective multicenter study revealed that predefined pharmacokinetic/pharmacodynamic targets often were not attained ..read more
Visit website
Stopping the Cycle of Recurrent Bacterial Vaginosis
NEJM Journal Watch: Infectious Diseases
by Abigail Zuger, MD
2w ago
Treating male partners with two drugs halved the recurrence rate ..read more
Visit website

Follow NEJM Journal Watch: Infectious Diseases on FeedSpot

Continue with Google
Continue with Apple
OR